MedPath

ABX-1431

Generic Name
ABX-1431
Drug Type
Small Molecule
Chemical Formula
C20H22F9N3O2
CAS Number
1446817-84-0
Unique Ingredient Identifier
FB39E94UXK

Overview

ABX-1431 is under investigation in clinical trial NCT03625453 (Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder).

Background

ABX-1431 is under investigation in clinical trial NCT03625453 (Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
Phase 2
Completed
Posted: 2018/08/10
Sponsor:
Abide Therapeutics
ID:NCT03625453
Titration Study of ABX-1431
Phase 1
Completed
Posted: 2018/02/27
Sponsor:
Abide Therapeutics
ID:NCT03447756
Central Pain Study for ABX-1431
Phase 1
Completed
Posted: 2017/05/03
Sponsor:
Abide Therapeutics
ID:NCT03138421
A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
Phase 1
Completed
Posted: 2017/02/23
Sponsor:
Abide Therapeutics
ID:NCT03058562
An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates
Phase 1
Completed
Posted: 2016/10/11
Sponsor:
Abide Therapeutics
ID:NCT02929264

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy